JBS (NYSE:JBS) Stock Rating Lowered by Zacks Research

JBS (NYSE:JBSGet Free Report) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Thursday,Zacks.com reports.

Several other research analysts also recently commented on the company. Weiss Ratings downgraded JBS from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, June 1st. Mizuho upgraded JBS to a “strong-buy” rating in a research note on Friday, April 10th. UBS Group set a $17.00 target price on JBS in a research note on Tuesday, May 19th. JPMorgan Chase & Co. downgraded JBS from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $20.50 to $18.50 in a research note on Thursday, May 14th. Finally, Barclays cut their target price on JBS from $23.00 to $21.00 and set an “overweight” rating for the company in a research note on Thursday, May 14th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

Read Our Latest Report on JBS

JBS Stock Performance

NYSE:JBS opened at $12.52 on Thursday. The business’s fifty day moving average is $15.09 and its 200 day moving average is $15.19. The firm has a market cap of $9.72 billion and a price-to-earnings ratio of 7.88. The company has a debt-to-equity ratio of 2.42, a quick ratio of 0.77 and a current ratio of 1.50. JBS has a 52-week low of $11.49 and a 52-week high of $18.65.

JBS (NYSE:JBSGet Free Report) last issued its earnings results on Tuesday, May 12th. The company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.08). JBS had a return on equity of 19.28% and a net margin of 1.98%.The company had revenue of $21.61 billion during the quarter. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. Research analysts predict that JBS will post 1.45 EPS for the current year.

Institutional Trading of JBS

Several institutional investors and hedge funds have recently modified their holdings of the business. BNDES Participacoes S.A. purchased a new stake in shares of JBS in the 4th quarter valued at about $2,874,074,000. Davis Selected Advisers purchased a new position in shares of JBS during the 4th quarter valued at about $170,945,000. Banco BTG Pactual S.A. purchased a new position in shares of JBS during the 3rd quarter valued at about $143,175,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of JBS by 117.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 7,687,775 shares of the company’s stock valued at $138,072,000 after buying an additional 4,147,304 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in shares of JBS by 23,891.7% during the 3rd quarter. Ameriprise Financial Inc. now owns 6,583,073 shares of the company’s stock valued at $98,285,000 after buying an additional 6,555,634 shares in the last quarter.

About JBS

(Get Free Report)

JBS SA is a global leader in the production and processing of meat products, with a focus on beef, pork and poultry. Headquartered in São Paulo, Brazil, the company operates through an extensive network of owned facilities and partnerships that span the Americas, Europe and the Asia-Pacific region. JBS supplies fresh, frozen and value-added protein solutions for retail, foodservice and industrial customers, and is active across the entire supply chain—from livestock procurement and feed production to slaughtering, processing, packaging and distribution.

Founded in 1953 by José Batista Sobrinho in Anápolis, Goiás, JBS began as a small slaughterhouse and expanded rapidly through strategic acquisitions and organic growth.

Featured Articles

Analyst Recommendations for JBS (NYSE:JBS)

Receive News & Ratings for JBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBS and related companies with MarketBeat.com's FREE daily email newsletter.